These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 13002066)

  • 21. The effects of EF-Ts and bismuth on EF-Tu in Helicobacter pylori: implications for an elegant timing for the introduction of EF-Ts in the elongation and EF-Tu as a potential drug target.
    Wang D; Luo B; Shan W; Hao M; Sun X; Ge R
    Metallomics; 2013 Jun; 5(7):888-95. PubMed ID: 23765120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental study of bismuth subnitrate effect on glycoconjugates biosynthesis in rat intestinal mucosa and brain (author's transl)].
    Martin A; Biol MC; Richard M; Louisot P
    Gastroenterol Clin Biol; 1978; 2(8-9):729-35. PubMed ID: 710815
    [No Abstract]   [Full Text] [Related]  

  • 23. [In vitro studies on effect of particle size of bismuth subcarbonate on antacid effectiveness].
    Liu CT; He GW
    Yao Xue Xue Bao; 1983 Aug; 18(8):630-2. PubMed ID: 6677046
    [No Abstract]   [Full Text] [Related]  

  • 24. Eryptosis triggered by bismuth.
    Braun M; Föller M; Gulbins E; Lang F
    Biometals; 2009 Jun; 22(3):453-60. PubMed ID: 19048190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerance of atypical mycobacteria: the effect of metal ions in various concentrations.
    Chapman JS; Speight M
    Am Rev Respir Dis; 1971 Mar; 103(3):372-6. PubMed ID: 5152722
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of subsalicylate bismuth on absorption of doxycycline.
    Ericsson CD; Feldman S; Pickering LK; Cleary TG
    JAMA; 1982 Apr; 247(16):2266-7. PubMed ID: 7040708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of oral administration of bismuth subnitrate on distribution and excretion of intraperitoneally given radiobismuth in rats (author's transl)].
    Chaleil D; Allain P
    Ann Pharm Fr; 1979; 37(7-8):285-90. PubMed ID: 539736
    [No Abstract]   [Full Text] [Related]  

  • 28. An evaluation of a bismuth aluminate antacid.
    Rider JA; Moeller HC; Gibbs JO; Puletti EJ; Desai DC
    Curr Ther Res Clin Exp; 1968 Mar; 10(3):109-15. PubMed ID: 4966996
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effect of a calcium carbonate-bismuth subsalicylate combination on intragastric acidity over the course of 24 hours. A randomized study of healthy probands].
    Hopert R; Emde C; Barner M; Vallo-Wermes M; Riecken EO
    Med Klin (Munich); 1989 Mar; 84(3):135-8. PubMed ID: 2716711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bismuth uptake in rat testicular macrophages: a follow-up observation suggesting that bismuth alters interactions between testicular macrophages and Leydig cells.
    Stoltenberg M; Hutson JC
    J Histochem Cytochem; 2004 Sep; 52(9):1241-3. PubMed ID: 15314091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [On the antitrypanosomal action of hydrosoluble compounds of bismuth].
    FERRARI M
    Boll Ist Sieroter Milan; 1961; 40():61-4. PubMed ID: 13699056
    [No Abstract]   [Full Text] [Related]  

  • 32. A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid.
    Lee SP
    Scand J Gastroenterol Suppl; 1982; 80():17-21. PubMed ID: 6962540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of the Pseudomonas aeruginosa PA01 Intercellular Signaling Pathway (Quorum Sensing) Functioning in Presence of Porphyrins Bismuth Complexes.
    Galkin M; Ivanitsia V; Ishkov Y; Galkin B; Filipova T
    Pol J Microbiol; 2015; 64(2):101-6. PubMed ID: 26373168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of antibiotics and bismuth on sulfate-reducing bacteria].
    Ohge H; Madoff RD; Levitt MD
    Jpn J Antibiot; 2003 Aug; 56(4):339-40. PubMed ID: 14567258
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the pharmacokinetics of bismuth compounds].
    Coghi S; Bonisoli-Alquati D; Raspa A; Vettori G
    Boll Soc Ital Biol Sper; 1968 Feb; 44(3):182-6. PubMed ID: 4972121
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bismuth in the Allium test: a problem in comparative toxicology].
    Bournique CP; Deysson G
    Ann Pharm Fr; 1976; 34(5-6):193-8. PubMed ID: 999156
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of fumarase by bismuth(III): implications for the tricarboxylic acid cycle as a potential target of bismuth drugs in Helicobacter pylori.
    Chen Z; Zhou Q; Ge R
    Biometals; 2012 Feb; 25(1):95-102. PubMed ID: 21818585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characteristics of the effect of bismuth lead in experimental studies].
    Babkin VA; Petrov BA
    Gig Tr Prof Zabol; 1989; (3):52-4. PubMed ID: 2744562
    [No Abstract]   [Full Text] [Related]  

  • 39. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Wagstaff AJ; Benfield P; Monk JP
    Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inorganic bismuth(III) compounds in the therapy.
    Wesolowski M
    Arzneimittelforschung; 1978; 28(3):372-8. PubMed ID: 350231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.